Oxandrolone (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Oxandrolone drug offered from Par Pharmaceutical, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: oxandrolone
SUBSTANCE NAME: OXANDROLONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2007-08-20
END MARKETING DATE: 0000-00-00


Oxandrolone HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOxandrolone from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2007-08-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-301_b6abfdb5-35c6-4551-9af6-fc9ba287b310
PRODUCT NDC: 49884-301
APPLICATION NUMBER: ANDA077827

Other OXANDROLONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingOxandrolone
Par Pharmaceutical, Inc.Oxandrolone
Upsher-Smith Laboratories, LLCOxandrolone